https://www.selleckchem.com/products/MK-1775.html
4243). The mean age of the population growth 5.7 years (p=0.008). The changes in female male ratio (12.9%), in the age at the first symptom (2.2 years), and the diagnosis delay (0.12 years) did not achieve significance (p=0.7750, 0.1606, 0.8581). The prevalence of MS doubled in 12 years whilst the difference in incidence was lower and not significant. The disproportion in the growth of both parameters, as well as the higher mean age in the last study, suggest a longer survival of patients with MS. The prevalence of MS doubled in 12 year